• Are there more optimal approaches to managing pricing and reimbursement of multi-indication medicines to better facilitate patient access?

  • We invite you to join our ‘multi-indication product community’ to stay informed of project updates and/or be involved in future work*

  • Please tick which of the options below you are interested in:*
  • *Disclaimer

    We cannot guarantee, but will do our best to include / consult everyone interested in participating, depending on nature of the project.
  • Should be Empty: